Literature DB >> 29250230

Ablation of "Background Tachycardia" in Long Standing Atrial Fibrillation: Improving the Outcomes by Unmasking a Residual Atrial Fibrillation Perpetuator.

José Carlos Pachón-M1, Enrique I Pachón-M1, Tomas G Santillana P1, Tasso Julio Lobo1, Carlos Thiene C Pachón1, Juán Carlos Pachón-M1, Remy Nelson Albornoz V1, Juán Carlos Zerpa A1, Felipe Ortencio1, Mauricio Arruda1.   

Abstract

BACKGROUND: Catheter ablation of long-standing persistent AF (LSAF) remains challenging. Since AF-Nest (AFN) description, we have observed that a stable, protected, fast source firing, namely "Background Tachycardia"(BT), could be hidden beneath the chaotic AF. Following pulmonary vein isolation (PVI)+AFN ablation one or more BT may arise or be induced in 30-40% of patients, which could be the culprit forAF maintenance and ablation recurrences. METHODS AND
RESULTS: We studied 114 patients, from 322 sequential LSAF regular ablations, having spontaneous or induced residual BT after EGM-guided PVI+AFN ablation of LSAF; 55.6±11y/o, 97males (85.1%), EF=65.5±8%, LA=42.8±6.7mm. Macroreentrant tachycardias were excluded. Pre-ablationAF 12-leads ECG Digital processing(DP) and spectral analysis(SA) was performed searching for BT before AF ablation and its correlation with BT during ablation.After PVI, 38.1±9 AFN sites/patient and 135 sustained BTs (1-3, 1.2±0.5/patient) were ablated. BT cycle length(CL) was 246.3±37.3ms. In 79 patients presenting suitable DP for SA, the BT-CL was 241.6±34.3ms with intra procedure BT-CL correlation r=0.83/p<0.01. Following BT ablation, AF could not be induced. During FU of 13→60 months(22.8±12m), AF freedom for BT RF(+) vs. BT RF(-) groups were 77.9% vs. 56.4% (p=0.009), respectively. There was no significant complication.
CONCLUSION: BT ablation following PVI and AFN ablation improved long-term outcomes ofLSAF ablation. BT is likely due to sustained microreentry, protected during AF by entry block. BT can be suspected by spectral analysis of the pre-ablation ECG and is likely one important AF perpetuator by causing electrical resonance of the AFN. This ablation strategy warrants randomized, multicenter investigation.

Entities:  

Keywords:  AF-Nest; Ablation; Arrhythmia; Atrial fibrillation; Rotors; Spectral Analysis

Year:  2017        PMID: 29250230      PMCID: PMC5673289          DOI: 10.4022/jafib.1583

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  37 in total

1.  Pulmonary vein stenosis after radiofrequency ablation of atrial fibrillation: functional characterization, evolution, and influence of the ablation strategy.

Authors:  Eduardo B Saad; Antonio Rossillo; Cynthia P Saad; David O Martin; Mandeep Bhargava; Demet Erciyes; Dianna Bash; Michelle Williams-Andrews; Salwa Beheiry; Nassir F Marrouche; James Adams; Ennio Pisanò; Raffaele Fanelli; Domenico Potenza; Antonio Raviele; Aldo Bonso; Sakis Themistoclakis; Joannes Brachmann; Walid I Saliba; Robert A Schweikert; Andrea Natale
Journal:  Circulation       Date:  2003-11-17       Impact factor: 29.690

Review 2.  Treatment of paroxysmal atrial fibrillation by pulmonary vein isolation.

Authors:  Fred Morady
Journal:  Circ J       Date:  2003-07       Impact factor: 2.993

Review 3.  Pulmonary vein isolation for treatment of atrial fibrillation: recent updates.

Authors:  Niranjan Seshadri; Nassir F Marrouche; David Wilber; Douglas Packer; Andrea Natale
Journal:  Pacing Clin Electrophysiol       Date:  2003-07       Impact factor: 1.976

4.  Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci.

Authors:  M Haïssaguerre; P Jaïs; D C Shah; S Garrigue; A Takahashi; T Lavergne; M Hocini; J T Peng; R Roudaut; J Clémenty
Journal:  Circulation       Date:  2000-03-28       Impact factor: 29.690

5.  Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation.

Authors:  C Pappone; S Rosanio; G Oreto; M Tocchi; F Gugliotta; G Vicedomini; A Salvati; C Dicandia; P Mazzone; V Santinelli; S Gulletta; S Chierchia
Journal:  Circulation       Date:  2000-11-21       Impact factor: 29.690

6.  Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation.

Authors:  Hakan Oral; Bradley P Knight; Hiroshi Tada; Mehmet Ozaydin; Aman Chugh; Sohail Hassan; Christoph Scharf; Steve W K Lai; Radmira Greenstein; Frank Pelosi; S Adam Strickberger; Fred Morady
Journal:  Circulation       Date:  2002-03-05       Impact factor: 29.690

Review 7.  Evolution of non-pharmacological curative therapy for atrial fibrillation. Where do we stand today?

Authors:  Carlo Pappone; Salvatore Rosanio
Journal:  Int J Cardiol       Date:  2003-04       Impact factor: 4.164

Review 8.  Rotors and spiral waves in atrial fibrillation.

Authors:  José Jalife
Journal:  J Cardiovasc Electrophysiol       Date:  2003-07

9.  A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate.

Authors:  Koonlawee Nademanee; John McKenzie; Erol Kosar; Mark Schwab; Buncha Sunsaneewitayakul; Thaveekiat Vasavakul; Chotikorn Khunnawat; Tachapong Ngarmukos
Journal:  J Am Coll Cardiol       Date:  2004-06-02       Impact factor: 24.094

10.  Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation.

Authors:  Carlo Pappone; Hakan Oral; Vincenzo Santinelli; Gabriele Vicedomini; Christopher C Lang; Francesco Manguso; Lucia Torracca; Stefano Benussi; Ottavio Alfieri; Robert Hong; William Lau; Kirk Hirata; Neil Shikuma; Burr Hall; Fred Morady
Journal:  Circulation       Date:  2004-05-24       Impact factor: 29.690

View more
  2 in total

1.  Role of the Autonomic Nervous System in Atrial Fibrillation.

Authors:  Enrique Indalécio Pachón Mateo
Journal:  Arq Bras Cardiol       Date:  2021-11       Impact factor: 2.000

Review 2.  Surgical Treatment of Atrial Fibrillation: Cutting Through the Edges.

Authors:  Amer Harky; Christiana Bithas; Jeffrey Shi Kai Chan; Mostafa Snosi; Dimitrios Pousios; Andrew D Muir
Journal:  Braz J Cardiovasc Surg       Date:  2020-06-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.